Exciting Results in Recent Alzheimer’s Research
More good news on Alzheimer’s research! It is so wonderful that we are hearing of positive, measurable results coming from several studies. While it may be early for them, anything that may help stop or delay Alzheimer’s disease is promising.
Biogen announced Friday, March 20th, better than expected results in a study using Aducanumab. In a small study of 166 participants, those taking the drug (versus those receiving the placebo) showed several points less decline. You can read details of the numbers in my article, Alzheimer’s Disease in the News, published on Jaquo Lifestyle Magazine. When you consider the points apply to a 30 point test, it is clear the results deserve our hope.
Since there is no cure or even treatment yet, even a percentage or two of delay and/or improvement would be an excellent start. That’s true for the sake of the person with Alzheimer’s as well as for the nation as a whole. If you read my article, The Frightening Future of Alzheimer’s Disease, you will understand the unsustainable costs of caring for those with Alzheimer’s. The numbers, if they aren’t stopped or slowed, are overwhelming.
Next Phase will Begin This Year
The next phase for this study will be on a larger number of people. Often that lowers the success of a study, so we are warned that it may not work as well in the next phase. I will still get my hopes up! Between this study and the Ultra sound study that has shown success in removing amyloid plaque in the brain, we may see a solid treatment in the next few years.